TP53 and neoplasm: Altogether, p53 activation can directly enhance T cell antitumor immunity by selecting effectively activated effector T cells and indirectly by stimulating innate immune responses that enhance the tumor antigen update, presentation, and activation of myeloid cells for promoting activation of tumor antigen-specific adaptive immunity.